In a new filing (SC 13G) with the Securities and Exchange Commission (SEC), billionaire Steve Cohen's Point72 Asset Management, L.P. has disclosed a 5% (5,879,244 shares) stake in Achillion Pharmaceuticals, Inc. (ACHN) .
ACHN recently announced an agreement with Janssen Pharmaceuticals to develop and commercialize one or more of ACHN's lead hepatitis C virus (HCV) assets, including ACH-3102, ACH-3422, and sovaprevir. According to the company, the deal calls for up to $1.1 billion in potential development, regulatory and sales milestone payments and a separate equity investment.
ACHN, a biopharmaceutical company, focuses on developing combination therapies for the treatment of chronic hepatitis C (HCV) infection and drug-resistant bacterial infections.
More about Achillion Pharmaceuticals, Inc. (ACHN) at www.achillion.com
**
On Friday, Stonepine Capital, L.P. disclosed in an SEC filing (SC 13G) a 5.2% (1,500,000 shares) stake in Aegerion Pharmaceuticals, Inc. (AEGR) .
AEGR reported total net product sales of $59.4 million for the first quarter and expects to generate positive cash flow from operations for the full year 2015.
AEGR is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.
More about Aegerion Pharmaceuticals, Inc. (AEGR) at www.aegerion.com
**
After the closing bell on Friday, Enstar Group Ltd. (ESGR) said that Canada Pension Plan Investment Board, a professional investment management organization, has entered into an agreement to acquire approximately 1.9 million voting and non-voting ordinary shares of the company from private equity firm First Reserve.
The shares represent an approximately 9.9% stake in ESGR and the transaction is expected to be completed next week.
ESGR reported consolidated net earnings of $44.8 million (or $2.32 per fully diluted share) for the first quarter ended March 31, 2015.
ESGR and its operating subsidiaries acquire and manage diversified insurance businesses through a network of service companies in Bermuda, the United States, the United Kingdom, Continental Europe, Australia, and other international locations.
More about Enstar Group Ltd. (ESGR) at www.enstargroup.com
**
Crown Equity Holdings Inc. (CRWE) has updated its business plan ( http://crownequityholdings.com/extras/Business_Plan.pdf )
The company is currently developing its CRWE PR Network, which disseminates community, state, national and global news & information and is also the portal in promoting the company's services, such as its business directory, business-to-business global trading, real estate, press release and video distribution, discounted vouchers and advertising platforms.
CRWE's growing network of community targeted sites is expected to be a one-stop shop for the various needs of consumers.
The company's CRWE Real Estate ( www.CRWERealEstate.com ) is expected to be integrated in all the CRWE PR Network. It will allow people to submit their listings for exposure to visitors searching for homes.
CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
**
Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer
ACHN recently announced an agreement with Janssen Pharmaceuticals to develop and commercialize one or more of ACHN's lead hepatitis C virus (HCV) assets, including ACH-3102, ACH-3422, and sovaprevir. According to the company, the deal calls for up to $1.1 billion in potential development, regulatory and sales milestone payments and a separate equity investment.
ACHN, a biopharmaceutical company, focuses on developing combination therapies for the treatment of chronic hepatitis C (HCV) infection and drug-resistant bacterial infections.
More about Achillion Pharmaceuticals, Inc. (ACHN) at www.achillion.com
**
On Friday, Stonepine Capital, L.P. disclosed in an SEC filing (SC 13G) a 5.2% (1,500,000 shares) stake in Aegerion Pharmaceuticals, Inc. (AEGR) .
AEGR reported total net product sales of $59.4 million for the first quarter and expects to generate positive cash flow from operations for the full year 2015.
AEGR is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.
More about Aegerion Pharmaceuticals, Inc. (AEGR) at www.aegerion.com
**
After the closing bell on Friday, Enstar Group Ltd. (ESGR) said that Canada Pension Plan Investment Board, a professional investment management organization, has entered into an agreement to acquire approximately 1.9 million voting and non-voting ordinary shares of the company from private equity firm First Reserve.
The shares represent an approximately 9.9% stake in ESGR and the transaction is expected to be completed next week.
ESGR reported consolidated net earnings of $44.8 million (or $2.32 per fully diluted share) for the first quarter ended March 31, 2015.
ESGR and its operating subsidiaries acquire and manage diversified insurance businesses through a network of service companies in Bermuda, the United States, the United Kingdom, Continental Europe, Australia, and other international locations.
More about Enstar Group Ltd. (ESGR) at www.enstargroup.com
**
Crown Equity Holdings Inc. (CRWE) has updated its business plan ( http://crownequityholdings.com/extras/Business_Plan.pdf )
The company is currently developing its CRWE PR Network, which disseminates community, state, national and global news & information and is also the portal in promoting the company's services, such as its business directory, business-to-business global trading, real estate, press release and video distribution, discounted vouchers and advertising platforms.
CRWE's growing network of community targeted sites is expected to be a one-stop shop for the various needs of consumers.
The company's CRWE Real Estate ( www.CRWERealEstate.com ) is expected to be integrated in all the CRWE PR Network. It will allow people to submit their listings for exposure to visitors searching for homes.
CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
**
Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer
